We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Thermo Fisher Scientific Inc | NYSE:TMO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 15.10 | 2.61% | 593.03 | 594.025 | 578.81 | 580.17 | 1,328,834 | 01:00:00 |
From May 2023 to May 2024
By Colin Kellaher
Life-sciences giant Thermo Fisher Scientific has struck a $3.1 billion deal to buy Swedish proteomics company Olink Holding.
Thermo Fisher on Tuesday said it will pay $26 a share in cash for Olink, a nearly 74% premium to Monday's closing price of $14.98.
Thermo Fisher said the acquisition of Olink, which offers solutions for advanced proteomics discovery and development, is highly complementary to its mass-spectrometry and life-sciences platforms.
Thermo Fisher, based in Waltham, Mass., plans to fund the acquisition with cash on hand and debt financing, adding that the deal is slated to close by mid-2024.
Trading in shares of Olink was halted premarket on Tuesday.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 17, 2023 08:46 ET (12:46 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Thermo Fisher Scientific Chart |
1 Month Thermo Fisher Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
